No Data
No Data
No Data
No Data
No Data
Earnings Preview: Exelixis to Report Financial Results Post-market on April 30
$Exelixis(EXEL.US)$ is scheduled to release its financial results post-market on April 30. Earnings PreviewAnalysts estimate $Exelixis(EXEL.US)$ to post revenue of USD456.51 million for 2024Q1, up 11.
Futu NewsApr 25 09:00
Market Participants Recognise Exelixis, Inc.'s (NASDAQ:EXEL) Earnings
Exelixis, Inc.'s (NASDAQ:EXEL) price-to-earnings (or "P/E") ratio of 32x might make it look like a strong sell right now compared to the market in the United States, where around half of the companies
Simply Wall StApr 22 21:36
Pheochromocytoma Pipeline Insight Report 2024, Featuring Genentech, Exelixis, Advanced Accelerator Applications, Enterome, FUJIFILM Toyama Chemical, Ipsen, Pfizer and Astex Pharmaceuticals
Yahoo FinanceApr 18 18:03
Institutional Investors in Exelixis, Inc. (NASDAQ:EXEL) Lost 3.8% Last Week but Have Reaped the Benefits of Longer-term Growth
Yahoo FinanceApr 17 22:20
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 16, 2024-- Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2024 fin
ExelixisApr 16 12:00
Unusual Options Activity: FYBR, TECK and Others Attract Market Bets, FYBR V/OI Ratio Reaches 169.5
EST Apr 15th Afternoon Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends
Futu NewsApr 16 01:30
No Data
No Data